Blog

Immunotherapy for peanut allergy safe, effective in clinical trial – UPI.com


UPI.com

Immunotherapy for peanut allergy safe, effective in clinical trial
UPI.com
The idea of using immunotherapy for peanut allergy is not new, as previous research has shown it may be effective. In 2016, the Learning Early About Peanut Allergy trial found infants who consumed 2 grams of peanut protein three times per week led to
AR101 oral immunotherapy effective in reducing severity of peanut allergyHealio


Peanut OIT Therapy Sees Success, Boosting Hope for FDA ApprovalAllergic Living
Aimmune Therapeutics' Pivotal Phase 3 PALISADE Trial of AR101 Meets Primary Endpoint in Patients With Peanut …Markets Insider
PharmaTimes
all 69 news articles »

2018-02-21 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.